BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19621006)

  • 41. A look at drug eluting stents with optical coherence tomography.
    de Smet BJ; Zijlstra F
    Eur Heart J; 2007 Apr; 28(8):918-9. PubMed ID: 17347174
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevention and treatment of thrombosis after implantation of drug-eluting stents].
    Han YL
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1516-7. PubMed ID: 17785098
    [No Abstract]   [Full Text] [Related]  

  • 43. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Live by the sword, die by the sword.
    Moreno R; Macaya C
    South Med J; 2008 Feb; 101(2):123-4. PubMed ID: 18364608
    [No Abstract]   [Full Text] [Related]  

  • 45. [Drug eluting stent thrombosis: light in the darkness and a defense of the obvious].
    Iñiguez Romo A
    Rev Esp Cardiol; 2008 Jul; 61(7):674-7. PubMed ID: 18590639
    [No Abstract]   [Full Text] [Related]  

  • 46. The quest for a 'better mousetrap'.
    Kugelmass AD
    Eur Heart J; 2009 Oct; 30(20):2431-2. PubMed ID: 19720639
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-eluting versus bare-metal stents in acute myocardial infarction.
    Kim DH
    N Engl J Med; 2009 Jan; 360(3):300-1; author reply 301-2. PubMed ID: 19148960
    [No Abstract]   [Full Text] [Related]  

  • 48. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
    Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are drug-eluting stents safe in the long term?
    Généreux P; Mehran R
    CMAJ; 2009 Jan; 180(2):154-5. PubMed ID: 19106153
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
    Bittl JA
    J Am Coll Cardiol; 2009 Mar; 53(11):929-30. PubMed ID: 19281921
    [No Abstract]   [Full Text] [Related]  

  • 51. Stenting LAD myocardial bridges: is the glass half empty or..
    Tobis J
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):197. PubMed ID: 18327837
    [No Abstract]   [Full Text] [Related]  

  • 52. Choice of stents -- Balancing subacute thrombosis and restenosis.
    Sethi KK; Lahiri S
    Indian Heart J; 2009; 61(1):61-7. PubMed ID: 19729692
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-eluting versus bare-metal stents in acute myocardial infarction.
    Rothman KJ
    N Engl J Med; 2009 Jan; 360(3):301; author reply 301-2. PubMed ID: 19148961
    [No Abstract]   [Full Text] [Related]  

  • 54. Getting real with drug-eluting stents: 5-year follow up of a real-world cohort.
    Sakhuja R; Bhatt DL
    Am Heart J; 2009 May; 157(5):802-4. PubMed ID: 19376303
    [No Abstract]   [Full Text] [Related]  

  • 55. The battle against stent thrombosis--to protect and to serve.
    Byrne RA; Kastrati A; Hausleiter J
    Lancet; 2012 Oct; 380(9851):1365-7. PubMed ID: 22951083
    [No Abstract]   [Full Text] [Related]  

  • 56. Application of drug eluting stents to clinical practice in Japan: are we going in the right direction?
    Aoki J
    Circ J; 2010 Aug; 74(8):1532-3. PubMed ID: 20647637
    [No Abstract]   [Full Text] [Related]  

  • 57. Stent selection in patients on oral anticoagulants: can we prevent restenosis and avoid bleeding?
    Steg PG; Ducrocq G
    EuroIntervention; 2009 Sep; 5(4):405, 407. PubMed ID: 19755324
    [No Abstract]   [Full Text] [Related]  

  • 58. Definition, incidence, correlates, and clinical impact of "nuisance" bleeding in patients undergoing drug-eluting stent implantation.
    Waksman R
    Am J Cardiol; 2009 Sep; 104(5 Suppl):30C-3C. PubMed ID: 19695358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-eluting stents and concomitant treatment.
    Akin I
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):219. PubMed ID: 25316406
    [No Abstract]   [Full Text] [Related]  

  • 60. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
    Silber S; Borggrefe M; Böhm M; Hoffmeister HM; Dietz R; Ertl G; Heusch G
    Clin Res Cardiol; 2008 Aug; 97(8):548-63. PubMed ID: 18726643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.